2524 Stock Overview
Guangzheng Eye Hospital Group Co., Ltd. provides various ophthalmic medical services in China.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Guangzheng Eye Hospital Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.12 |
52 Week High | CN¥7.79 |
52 Week Low | CN¥3.36 |
Beta | 0.53 |
1 Month Change | 14.54% |
3 Month Change | -19.62% |
1 Year Change | -27.48% |
3 Year Change | -49.36% |
5 Year Change | -5.54% |
Change since IPO | -41.19% |
Recent News & Updates
Shareholder Returns
2524 | CN Healthcare | CN Market | |
---|---|---|---|
7D | 6.4% | -2.9% | -0.03% |
1Y | -27.5% | -28.9% | -14.2% |
Return vs Industry: 002524 exceeded the CN Healthcare industry which returned -28.9% over the past year.
Return vs Market: 002524 underperformed the CN Market which returned -14.2% over the past year.
Price Volatility
2524 volatility | |
---|---|
2524 Average Weekly Movement | 8.1% |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.3% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 002524's share price has been volatile over the past 3 months.
Volatility Over Time: 002524's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Yonglin Zhou | https://www.gzykcn.com |
Guangzheng Eye Hospital Group Co., Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure, Energy, and Medical and Health Sector segments.
Guangzheng Eye Hospital Group Co., Ltd. Fundamentals Summary
2524 fundamental statistics | |
---|---|
Market cap | CN¥2.63b |
Earnings (TTM) | -CN¥200.00m |
Revenue (TTM) | CN¥1.02b |
2.6x
P/S Ratio-13.2x
P/E RatioIs 2524 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2524 income statement (TTM) | |
---|---|
Revenue | CN¥1.02b |
Cost of Revenue | CN¥706.49m |
Gross Profit | CN¥315.53m |
Other Expenses | CN¥515.53m |
Earnings | -CN¥200.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | -0.39 |
Gross Margin | 30.87% |
Net Profit Margin | -19.57% |
Debt/Equity Ratio | 157.2% |
How did 2524 perform over the long term?
See historical performance and comparison